127 related articles for article (PubMed ID: 20508390)
1. Interactions of human organic anion transporters with aristolochic acids.
Babu E; Takeda M; Nishida R; Noshiro-Kofuji R; Yoshida M; Ueda S; Fukutomi T; Anzai N; Endou H
J Pharmacol Sci; 2010; 113(2):192-6. PubMed ID: 20508390
[TBL] [Abstract][Full Text] [Related]
2. Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy.
Bakhiya N; Arlt VM; Bahn A; Burckhardt G; Phillips DH; Glatt H
Toxicology; 2009 Oct; 264(1-2):74-9. PubMed ID: 19643159
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters.
Hashimoto T; Narikawa S; Huang XL; Minematsu T; Usui T; Kamimura H; Endou H
Drug Metab Dispos; 2004 Oct; 32(10):1096-102. PubMed ID: 15377641
[TBL] [Abstract][Full Text] [Related]
4. Interactions of human organic anion transporters with diuretics.
Hasannejad H; Takeda M; Taki K; Shin HJ; Babu E; Jutabha P; Khamdang S; Aleboyeh M; Onozato ML; Tojo A; Enomoto A; Anzai N; Narikawa S; Huang XL; Niwa T; Endou H
J Pharmacol Exp Ther; 2004 Mar; 308(3):1021-9. PubMed ID: 14610216
[TBL] [Abstract][Full Text] [Related]
5. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.
Takeda M; Khamdang S; Narikawa S; Kimura H; Kobayashi Y; Yamamoto T; Cha SH; Sekine T; Endou H
J Pharmacol Exp Ther; 2002 Mar; 300(3):918-24. PubMed ID: 11861798
[TBL] [Abstract][Full Text] [Related]
6. Human organic anion transporters mediate the transport of tetracycline.
Babu E; Takeda M; Narikawa S; Kobayashi Y; Yamamoto T; Cha SH; Sekine T; Sakthisekaran D; Endou H
Jpn J Pharmacol; 2002 Jan; 88(1):69-76. PubMed ID: 11855680
[TBL] [Abstract][Full Text] [Related]
7. Characterization of methotrexate transport and its drug interactions with human organic anion transporters.
Takeda M; Khamdang S; Narikawa S; Kimura H; Hosoyamada M; Cha SH; Sekine T; Endou H
J Pharmacol Exp Ther; 2002 Aug; 302(2):666-71. PubMed ID: 12130730
[TBL] [Abstract][Full Text] [Related]
8. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs.
Khamdang S; Takeda M; Noshiro R; Narikawa S; Enomoto A; Anzai N; Piyachaturawat P; Endou H
J Pharmacol Exp Ther; 2002 Nov; 303(2):534-9. PubMed ID: 12388633
[TBL] [Abstract][Full Text] [Related]
9. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.
Kimura H; Takeda M; Narikawa S; Enomoto A; Ichida K; Endou H
J Pharmacol Exp Ther; 2002 Apr; 301(1):293-8. PubMed ID: 11907186
[TBL] [Abstract][Full Text] [Related]
10. Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine.
Khamdang S; Takeda M; Shimoda M; Noshiro R; Narikawa S; Huang XL; Enomoto A; Piyachaturawat P; Endou H
J Pharmacol Sci; 2004 Feb; 94(2):197-202. PubMed ID: 14978359
[TBL] [Abstract][Full Text] [Related]
11. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity.
Enomoto A; Takeda M; Tojo A; Sekine T; Cha SH; Khamdang S; Takayama F; Aoyama I; Nakamura S; Endou H; Niwa T
J Am Soc Nephrol; 2002 Jul; 13(7):1711-20. PubMed ID: 12089366
[TBL] [Abstract][Full Text] [Related]
12. Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Pharmacol Res; 2012 Feb; 65(2):254-60. PubMed ID: 22108572
[TBL] [Abstract][Full Text] [Related]
13. Interactions of organic anion transporters and organic cation transporters with mycotoxins.
Tachampa K; Takeda M; Khamdang S; Noshiro-Kofuji R; Tsuda M; Jariyawat S; Fukutomi T; Sophasan S; Anzai N; Endou H
J Pharmacol Sci; 2008 Mar; 106(3):435-43. PubMed ID: 18319568
[TBL] [Abstract][Full Text] [Related]
14. Characterization of ochratoxin A transport by human organic anion transporters.
Jung KY; Takeda M; Kim DK; Tojo A; Narikawa S; Yoo BS; Hosoyamada M; Cha SH; Sekine T; Endou H
Life Sci; 2001 Sep; 69(18):2123-35. PubMed ID: 11669456
[TBL] [Abstract][Full Text] [Related]
15. Physiological and molecular characterization of aristolochic acid transport by the kidney.
Dickman KG; Sweet DH; Bonala R; Ray T; Wu A
J Pharmacol Exp Ther; 2011 Aug; 338(2):588-97. PubMed ID: 21546538
[TBL] [Abstract][Full Text] [Related]
16. Interactions of stevioside and steviol with renal organic anion transporters in S2 cells and mouse renal cortical slices.
Srimaroeng C; Jutabha P; Pritchard JB; Endou H; Chatsudthipong V
Pharm Res; 2005 Jun; 22(6):858-66. PubMed ID: 15948029
[TBL] [Abstract][Full Text] [Related]
17. Transport of aminopterin by human organic anion transporters hOAT1 and hOAT3: Comparison with methotrexate.
Uwai Y; Iwamoto K
Drug Metab Pharmacokinet; 2010; 25(2):163-9. PubMed ID: 20460822
[TBL] [Abstract][Full Text] [Related]
18. Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy.
Baudoux TE; Pozdzik AA; Arlt VM; De Prez EG; Antoine MH; Quellard N; Goujon JM; Nortier JL
Kidney Int; 2012 Nov; 82(10):1105-13. PubMed ID: 22854641
[TBL] [Abstract][Full Text] [Related]
19. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
Uwai Y; Ida H; Tsuji Y; Katsura T; Inui K
Pharm Res; 2007 Apr; 24(4):811-5. PubMed ID: 17372702
[TBL] [Abstract][Full Text] [Related]
20. Effects of phenylpropanoids on human organic anion transporters hOAT1 and hOAT3.
Kawasaki T; Takeichi Y; Tomita M; Uwai Y; Epifano F; Fiorito S; Taddeo VA; Genovese S; Nabekura T
Biochem Biophys Res Commun; 2017 Aug; 489(4):375-380. PubMed ID: 28559139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
